As of May 19, 2020, there are in total 4,986,200 laboratory-confirmed Coronavirus disease-2019 (COVID-19) cases. 2% (45,425) out of 2,657,390 active COVID-19 cases are critically ill and might be requiring intensive care support.(1,2) Unfortunately, even after six months since its first detection, we still do not have any definitive treatment options for COVID-19 pneumonia. This article is protected by copyright. All rights reserved.
Keywords: Coronavirus; Epidemiology; Virus classification.
This article is protected by copyright. All rights reserved.
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.Cochrane Database Syst Rev. 2020 May 14;5:CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. PMID: 32406927
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.JAMA. 2020 Mar 27;323(16):1582-9. doi: 10.1001/jama.2020.4783. Online ahead of print. JAMA. 2020. PMID: 32219428 Free PMC article.
Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review.Ultrasound Obstet Gynecol. 2020 May 19. doi: 10.1002/uog.22088. Online ahead of print. Ultrasound Obstet Gynecol. 2020. PMID: 32430957 Review.
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149. J Korean Med Sci. 2020. PMID: 32281317 Free PMC article.
Coronavirus disease 2019 (COVID-19): a clinical update.Front Med. 2020 Apr;14(2):126-135. doi: 10.1007/s11684-020-0767-8. Epub 2020 Apr 2. Front Med. 2020. PMID: 32240462 Free PMC article. Review.